Use of alternative medicine by patients with cancer in a rural area of Switzerland

Swiss Medical Weekly

Volumn 133, Issue 15-16, 2003, Pages 233-240

  Van der Weg, Fleur ^a   Streuli, Rolf A ^a  

^a Spital Region Oberaargau   (Switzerland)

Author keywords

Alternative medicine; Cancer; Oncology; Switzerland

Indexed keywords

VISCUM ALBUM EXTRACT;

ACUPUNCTURE; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CANCER; COLOR THERAPY; CRYSTAL; DIET THERAPY; DOCTOR PATIENT RELATION; FEEDBACK SYSTEM; FEMALE; FLOWER; HEALTH BEHAVIOR; HOMEOPATHY; HUMAN; HYPNOSIS; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MASSAGE; MOTIVATION; MUSIC THERAPY; PATIENT ATTITUDE; RELIGION; RURAL AREA; SELF CARE; SWITZERLAND; VISCUM ALBUM;

EID: 0038613514     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer. A systematic review. Cancer 1998;83:777-82.
2. Obrist R. Wer verwendet alternative Therapien bei Krebs? Eine Patientenbefragung. Schweiz Rundschau Med Prax 1989;8:1119-20.
3. Morant R, Jungi WF, Koehli C, Senn HJ. Warum benützen Tumorpatienten Alrernativmedizin? Schweiz Med Wochenschr 1991;121:1029-34.
4. Obrist R, von Meiss M, Obrecht JP. Verwendung paramedizinischer Behandlungsmethoden durch Tumorpatienten. Schweiz Med Wochenschr 1986;111:283-7.
5. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18:2505-14.
6. Bennett M, Lengacher C. Use of complementary therapies in a rural cancer population. Oncol Nuts Forum 1999;26:1287-94.
7. Cassileth BR, Chapman BA. Alternative and complementary cancer therapies. Cancer 1996;77:1026-34.
8. van der Zouwe N, van Dam FSAM, Aaronson NK, Hanewald GJFP. Alternatieve geneeswijzen bij kanker; omvang en achtergronden van het gebruik. Ned Tijdschr Geneeskd 1994;138:300-6.
9. Boon H, Stewart M, Kennard MA, Gray R, Sawka C, et al. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 2000;18:2515-21.
10. Berger DP, Obrist R, Obrecht JP. Tumorpatient und Paramedizin. Versuch einer Charakterisierung von Anwendern unkonventioneller Therapieverfahren in der Onkologie. Dtsch Med Wochenschr 1989;114:323-30.
11. Detmar SB, Aaronson NK, Wever LDV, Muller M, Schornagel JH. How are you feeling? Who wants to know? Patients' and oncologists' preferences for discussing health-related quality of life issues. J Clin Oncol 2000;18:3295-301.
12. Schweizerische Krebsliga: Linderung, Wohlbefinden und Entspannung. Komplementäre Methoden. 1999.
13. Ernst E, Resch KL, Mills S, Hill R, Mitchell A, Willoughby M, White A. Complementary medicine - a definition. Br J Gen Pract 1995;45:506.
14. Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 1994;309:86-9.
15. Risberg T, Lund E, Wist E, Kaasa S, Wilsgaard T. Cancer patients use of nonproven therapy: a 5-year follow-up study. J Clin Oncol 1998;16:6-12.
16. MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet 1996;347:569-73.
17. Thomas KJ, Carr J, Westlake L, Williams BT. Use of non-orthodox and conventional health care in Great Britain. BMJ 1991;302:207-10.
18. Risberg T, Lund E, Wist E, Dahl O, Sundström S, Andersen OK, Kaasa S. The use of non-proven therapy among patients treated in Norwegian oncologic departments. A cross-sectional national multicentre study. Eur J Cancer 1995;31A:1785-9.
19. Grothey A, Düppe J, Hasenburg A, Voigtmann R. Anwendung alternativmediznischer Methoden dutch onkologische Patienten. Dtsch. med. Wschr. 1998;123:923-9.
20. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States, prevalence, costs, patterns of use. N Engl J Med 1993;328:246-52.
21. Cassileth BR, Lusk EJ, Strouse TB, Bodenheimer BJ. Contemporary unorthodox treatments in cancer medicine, a study of patients, treatments and practitioners. Ann Intern Med 1984;101:105-12.
22. Cassileth BR, Lusk EJ, Guerry D, Blake AD, et al. Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. N Engl J Med 1991;324:1180-5.
23. Begbie SD, Kerestes ZL, Bell DR. Patterns of alternative medicine use by cancer patients. Med J Aus 1996;165:545-8.
24. Hauser SP. Paramedizinische Behandlung des Krebses. Schweiz Rundschau Med Prax 1981;70:988-92.
25. Burstein HJ. Discussing complementary therapies with cancer patients: what should we be talking about? J Clin Oncol 2000;18:2501-4.
26. Burstein HJ, Gelbers S, Guadagnoli E, Weeks JC. Use of alterntive medicine by women with early-stage breast cancer. N Engl J Med 1999;340:1733-9.
27. Cassileth BR. The social implications of questionable cancer therapies. Cancer 1989;63:1247-50.
28. Aldridge D. Europe looks at complementary medicine. BMJ 1989;299:1121-2.
29. Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D. Alternative therapies used by women with breast cancer in four ethnic populations. J Nat Cancer Inst 2000;92:42-7.
30. Antman K, Benson MC, Chabot J, Cobrinik D, Grann VR, Jacobson JS, Joe AK, Katz AE, Kelly K, Neugut AI, Russo D, Tiersten A, Weinstein IB. Complementary and alternative medicine: the role of the cancer center. J Clin Oncol 2001;19:55s-60s.
31. Kalder M, von Georgi R, Kullmer U, Hadji P, Münstedt K. Charakteristika von Aerztinnen und Aerzten in der Anwendung unkonventioneller und komplementärer Heilmethoden in der Onkologie. Geburtsh Frauenheilk 2001;61:26-30.
32. Münstedt K, Entezami A, Kullmer U. Onkologiche Misteltherapie zur Anwendung und Bewertung der Wirksamkeit duch Aerzte. Dtsch med Wschr 2000;125:1222-6.
33. Sawyer MG, Gannoni AF, Toogood IR, Antoiou G, Rice M. The use of alternative therapies by children with cancer. Med J Aus 1994;160:320-2.
34. Risberg T, Kaasa S, Wist E, Melsom H. Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway. Eur J Cancer 1997;33:575-80.
35. Jirillo A, Lacava J, Leone A, Lonardi F, Bonciarelli G. Survey on the use of questionable methods of cancer treatment. Tumori 1996;82:215-7.
36. Stoll BA. Can unothodox cancer therapy improve quality-of-life? Ann Oncol 1993;4:121-3.
37. Paltiel O, Avitzour M, Peretz T, Cherny N, Kaduri L, et al. Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol 2001;19:2439-48.
38. Astin JA. Why patients use alternative therapies. Results of a national study. JAMA 1998;279:1548-53.
39. LaMar S, McGinnis. Alternative therapies, 1990. An overview. Cancer 1991;67:1788-92.
40. Clinical Oncology Group. New Zealand cancer patients and alternative medicine. NZ Med J 1987;100:110-3.
41. Druss BG, Rosenheck RA. Association between use of unconventional therapies and conventional medical services. JAMA 1999;282:651-6.
42. Adler SR, Fosket JR. Disclosing complementary and alternative medicine use in the medical encounter. A qualitative study in women with breast cancer. J Fam Pract 1999;48:453-8.
43. Crocetti E, Crotti N, Montella M, Musso M. Complementary medicine and oncologistis attitudes:a survey in Italy. Tumori 1996;82:539-42.
44. Schweizerische Studiengruppefür komplementäre und alternative Methoden bei Krebs SKAK. Dokumentation für Fachpersonen. Schweizerische Krebsliga (1982-1996).